| Location: | London |
|---|---|
| Salary: | £38,419 to £51,755 |
| Hours: | Full Time |
| Contract Type: | Fixed-Term/Contract |
| Placed On: | 26th August 2026 |
|---|---|
| Closes: | 20th September 2026 |
| Job Ref: | 10499 |
About the Role
We are seeking a motivated Postdoctoral Research Associate to join a Pancreatic Cancer UK funded project at the Barts Cancer Institute (BCI), Queen Mary University of London. The project focuses on developing novel urine-based phosphoproteomic biomarkers for the early detection and personalised management of pancreatic ductal adenocarcinoma (PDAC).
About You
The successful candidate will be completing or will already hold a PhD in relevant field. You will have experience in mass spectrometry-based proteomics and/or phosphoproteomics, including protein extraction, phosphopeptide enrichment, LC-MS/MS workflows, and analysis of proteomics datasets using appropriate bioinformatic and statistical tools. You should have a strong interest in translational cancer research and knowledge of cancer signalling pathways, particularly kinase signalling and phosphorylation biology. Experience working with human biological samples, including urine, plasma or tissue, is essential. Experience with software and analysis tools such as R, Mascot, DIA-NN, or related platforms would be advantageous.
About the Institute
The Barts Cancer Institute (BCI) is a Cancer Research UK Centre of Excellence whose work aims to transform the lives of those with and at risk of cancer through innovative research in the laboratory, in patients and in populations. It is one of six institutes within The Faculty of Medicine and Dentistry (FMD) BCI is internationally renowned in many areas of cancer research and it combines ground-breaking basic research with the expertise of clinicians and clinician scientists from the Centre for Experimental Cancer Medicine and the Barts NHS Trust to achieve improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. BCI is committed in supporting and developing future cancer researchers through its extensive postgraduate training.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
Benefits
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities.
Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
Type / Role:
Subject Area(s):
Location(s):